UBS Group Issues Pessimistic Forecast for Kenvue (NYSE:KVUE) Stock Price

Key Points

• UBS lowered its price target on Kenvue from $19.00 to $18.00 and kept a "neutral" rating, implying roughly a 7.6% upside from the stock's current level.
• Analyst consensus remains a "Hold" with an average price target of about $19.50, as brokerage actions were mixed (three Buys and thirteen Holds reported).
• Shares fell about 3.3% to $16.72 on the day; Kenvue beat quarterly EPS estimates ($0.27 vs. $0.22) and reported $3.78B in revenue, with a market capitalization near $32 billion.

Kenvue (NYSE:KVUE - Get Free Report) had its price objective reduced by investment analysts at UBS Group from $19.00 to $18.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a "neutral" rating on the stock. UBS Group's target price suggests a potential upside of 7.63% from the company's current price.

Several other research firms also recently weighed in on KVUE. Canaccord Genuity Group increased their price objective on Kenvue from $17.00 to $18.00 and gave the company a "hold" rating in a report on Wednesday, February 18th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Kenvue in a research note on Friday, January 9th. Jefferies Financial Group cut shares of Kenvue from a "buy" rating to a "hold" rating and lowered their price target for the stock from $23.00 to $18.00 in a research note on Friday, January 30th. Argus raised shares of Kenvue to a "hold" rating in a research note on Friday, March 6th. Finally, Citigroup lifted their price target on Kenvue from $18.00 to $20.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 18th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $19.50.

Kenvue Stock Down 3.3%

Shares of KVUE stock traded down $0.58 during trading hours on Tuesday, reaching $16.72. 15,529,809 shares of the stock were exchanged, compared to its average volume of 39,994,559. The business's fifty day moving average is $17.98 and its two-hundred day moving average is $17.07. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. Kenvue has a 12-month low of $14.02 and a 12-month high of $25.17. The firm has a market capitalization of $32.06 billion, a P/E ratio of 21.66, a P/E/G ratio of 3.89 and a beta of 0.61.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period in the prior year, the firm earned $0.26 earnings per share. The business's quarterly revenue was up 3.2% compared to the same quarter last year. As a group, research analysts expect that Kenvue will post 1.14 EPS for the current fiscal year.

Institutional Trading of Kenvue

A number of institutional investors have recently modified their holdings of the company. Hsbc Holdings PLC grew its holdings in shares of Kenvue by 31.8% during the 4th quarter. Hsbc Holdings PLC now owns 5,106,368 shares of the company's stock worth $88,231,000 after purchasing an additional 1,230,957 shares during the period. Stance Capital LLC grew its holdings in shares of Kenvue by 14.1% during the 4th quarter. Stance Capital LLC now owns 80,721 shares of the company's stock worth $1,392,000 after purchasing an additional 9,961 shares during the period. World Investment Advisors grew its holdings in shares of Kenvue by 60.9% during the 4th quarter. World Investment Advisors now owns 19,670 shares of the company's stock worth $339,000 after purchasing an additional 7,444 shares during the period. Advisortrust Partners LLC purchased a new stake in shares of Kenvue during the 4th quarter worth about $325,000. Finally, Reflection Asset Management purchased a new stake in shares of Kenvue during the 4th quarter worth about $32,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.